DS
CLBT icon

David Shaw’s Cellebrite CLBT Stock Holding History

David Shaw’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,559
Closed -$515K – 4605
2025
Q4 		$515K Buy
+28,559
New +$513K ﹤0.01% 3919
2025
Q3 		– Sell
-18,854
Closed -$302K – 4598
2025
Q2 		$302K Sell
18,854
-227,488
-92% -$4.06M ﹤0.01% 3869
2025
Q1 		$4.79M Sell
246,342
-864,159
-78% -$18.2M ﹤0.01% 1924
2024
Q4 		$24.5M Buy
1,110,501
+155,086
+16% +$2.98M 0.02% 917
2024
Q3 		$16.1M Buy
955,415
+565,303
+145% +$8.39M 0.01% 1123
2024
Q2 		$4.66M Sell
390,112
-335,034
-46% -$3.74M ﹤0.01% 1909
2024
Q1 		$8.03M Buy
725,146
+254,038
+54% +$2.59M 0.01% 1532
2023
Q4 		$4.08M Buy
471,108
+315,488
+203% +$2.45M ﹤0.01% 2071
2023
Q3 		$1.19M Buy
155,620
+95,028
+157% +$713K ﹤0.01% 2957
2023
Q2 		$436K Buy
+60,592
New +$353K ﹤0.01% 3474
2022
Q2 		– Sell
-13,046
Closed -$83K – 5384
2022
Q1 		$83K Sell
13,046
-2,698
-17% -$17.9K ﹤0.01% 5037
2021
Q4 		$126K Buy
+15,744
New +$148K ﹤0.01% 5014

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

David Shaw's CLBT Position: Q1 2026 in Review

David Shaw sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 28,559 shares — an estimated $515K sold.

David Shaw first reported a position in CLBT in Q4 2021 and held it in 12 quarters. The position peaked at $24.5M in Q4 2024. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • David Shaw reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • David Shaw sold 28,559 Cellebrite shares in Q1 2026, an estimated $515K.
  • David Shaw first reported a position in Cellebrite in Q4 2021 and held it in 12 quarters.
  • David Shaw's Cellebrite position peaked at $24.5M in Q4 2024.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.